MRKR logo

Marker Therapeutics (MRKR) Current Liabilities

Annual Current Liabilities

$3.07 M
-$4.71 M-60.49%

December 31, 2023

Summary

Performance

1-Year Change

-60.49%

3-Year Change

-51.97%

5-Year Change

+9.67%

15-Year Change

+101.98%

MRKR Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

11.79%
MRKR annual total current liabilities is higher than 11.79% of companies in Healthcare sector

High & Low

All-time High

$28.01 M
MRKR annual total current liabilities is currently -89.02% below its historical high of $28.01 million

3-Year Low

$3.07 M
MRKR annual total current liabilities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
MRKR previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 25, 2025
MRKR next annual earnings announcement is scheduled for Mar 25, 2025

OtherMRKRbalance sheetmetrics:

Annual Total Liabilities

$3.07 M
MRKR annual total liabilities is $3.07 million

Annual Total Long Term Liabilities

$0.00
MRKR annual total long term liabilities is $0.00

Annual Total Assets

$17.13 M
MRKR annual total assets is $17.13 million

Annual Current Assets

$17.13 M
MRKR annual total current assets is $17.13 million

Quarterly Current Liabilities

$3.46 M
+$1.49 M+75.48%

September 30, 2024

Summary

Performance

3-Month Change

+75.48%

1-Year Change

+75.48%

3-Year Change

+75.48%

5-Year Change

-30.56%

MRKR Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

13.6%
MRKR quarterly total current liabilities is higher than 13.6% of companies in Healthcare sector

High & Low

All-time High

$31.46 M
MRKR quarterly total current liabilities is currently -89.00% below its historical high of $31.46 million

3-Year Low

$1.97 M
MRKR quarterly total current liabilities is currently +75.48% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MRKR previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 25, 2025
MRKR next earnings announcement is scheduled for Mar 25, 2025

OtherMRKRbalance sheetmetrics:

Quarterly Total Liabilities

$3.46 M
MRKR quarterly total liabilities is $3.46 million

Quarterly Long Term Liabilities

$0.00
MRKR quarterly total long term liabilities is $0.00

Quarterly Total Assets

$10.91 M
MRKR quarterly total assets is $10.91 million

Quarterly Current Assets

$10.91 M
MRKR quarterly total current assets is $10.91 million

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

Annual Current Liabilities

$3.07 M
MRKR annual total current liabilities is $3.07 million

Annual Accounts Payable

$961.00 K
MRKR annual accounts payable is $961.00 thousand

Annual Short Term Debt

-
MRKR annual short term debt value is unknown

MRKR Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-60.5%+75.5%
3 y3 years-52.0%+75.5%
5 y5 years+9.7%-30.6%

MRKR Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-76.2%at low-74.3%+75.5%
5 y5-year-76.2%+54.3%-74.3%+75.5%
alltimeall time-89.0%+1216.8%-89.0%+9731.8%

Marker Therapeutics Current Liabilities History

DateAnnualQuarterly
Sep 2024
-
$3.46 M(+75.5%)
Jun 2024
-
$1.97 M(-14.4%)
Mar 2024
-
$2.30 M(-25.1%)
Dec 2023
$3.07 M(-60.5%)
$3.07 M(+10.6%)
Sep 2023
-
$2.78 M(-4.8%)
Jun 2023
-
$2.92 M(-43.9%)
Mar 2023
-
$5.20 M(-33.1%)
Dec 2022
$7.78 M(-39.7%)
$7.78 M(-31.1%)
Sep 2022
-
$11.29 M(-16.2%)
Jun 2022
-
$13.47 M(+64.0%)
Mar 2022
-
$8.21 M(-36.3%)
Dec 2021
$12.90 M(+101.5%)
$12.90 M(+56.8%)
Sep 2021
-
$8.23 M(+45.4%)
Jun 2021
-
$5.66 M(+36.5%)
Mar 2021
-
$4.15 M(-35.2%)
Dec 2020
$6.40 M(+221.2%)
$6.40 M(+6.3%)
Sep 2020
-
$6.02 M(+20.9%)
Jun 2020
-
$4.98 M(+57.5%)
Mar 2020
-
$3.16 M(+58.8%)
Dec 2019
$1.99 M(-28.9%)
$1.99 M(-37.5%)
Sep 2019
-
$3.19 M(-0.6%)
Jun 2019
-
$3.21 M(+9.0%)
Mar 2019
-
$2.94 M(+4.9%)
Dec 2018
$2.80 M(+84.2%)
$2.80 M(-24.2%)
Sep 2018
-
$3.70 M(-1.2%)
Jun 2018
-
$3.75 M(+61.9%)
Mar 2018
-
$2.31 M(+52.0%)
Dec 2017
$1.52 M(-12.4%)
$1.52 M(-13.9%)
Sep 2017
-
$1.77 M(+12.2%)
Jun 2017
-
$1.58 M(-19.8%)
Mar 2017
-
$1.96 M(+13.1%)
Dec 2016
$1.74 M(-93.8%)
$1.74 M(-21.2%)
Sep 2016
-
$2.20 M(-90.5%)
Jun 2016
-
$23.12 M(-26.5%)
Mar 2016
-
$31.46 M(+12.3%)
Dec 2015
$28.01 M(+2143.9%)
$28.01 M(+216.6%)
Sep 2015
-
$8.85 M(-32.3%)
Jun 2015
-
$13.06 M(+295.6%)
Mar 2015
-
$3.30 M(+164.5%)
Dec 2014
$1.25 M(-85.9%)
$1.25 M(-4.0%)
Sep 2014
-
$1.30 M(-50.0%)
Jun 2014
-
$2.60 M(-53.7%)
Mar 2014
-
$5.62 M(-36.5%)
Dec 2013
$8.85 M(+44.3%)
$8.85 M(+68.4%)
Sep 2013
-
$5.25 M(+6.0%)
Jun 2013
-
$4.96 M(-12.3%)
Mar 2013
-
$5.65 M(-7.8%)
Dec 2012
$6.13 M
$6.13 M(+38.4%)
Sep 2012
-
$4.43 M(+14.1%)
Jun 2012
-
$3.88 M(+4.9%)
DateAnnualQuarterly
Mar 2012
-
$3.70 M(-2.6%)
Dec 2011
$3.80 M(-4.6%)
$3.80 M(+122.9%)
Sep 2011
-
$1.71 M(+24.4%)
Jun 2011
-
$1.37 M(-28.8%)
Mar 2011
-
$1.92 M(-51.7%)
Dec 2010
$3.98 M(+303.8%)
$3.98 M(+205.6%)
Sep 2010
-
$1.30 M(+47.3%)
Jun 2010
-
$884.70 K(-28.8%)
Mar 2010
-
$1.24 M(+26.0%)
Dec 2009
$986.40 K(-67.9%)
$986.40 K(+8.7%)
Sep 2009
-
$907.70 K(+7.3%)
Jun 2009
-
$846.20 K(-75.5%)
Mar 2009
-
$3.46 M(+12.5%)
Dec 2008
$3.08 M(+57.4%)
$3.08 M(+7.0%)
Sep 2008
-
$2.88 M(+7.5%)
Jun 2008
-
$2.68 M(+13.7%)
Mar 2008
-
$2.35 M(+20.4%)
Dec 2007
$1.95 M(-38.1%)
$1.95 M(+26.5%)
Sep 2007
-
$1.54 M(+59.6%)
Jun 2007
-
$967.60 K(-43.7%)
Mar 2007
-
$1.72 M(-45.5%)
Dec 2006
$3.15 M(+36.6%)
$3.15 M(+0.2%)
Sep 2006
-
$3.15 M(+26.0%)
Jun 2006
-
$2.50 M(+7.0%)
Mar 2006
-
$2.33 M(+1.0%)
Dec 2005
$2.31 M(-8.7%)
$2.31 M(+8.1%)
Sep 2005
-
$2.14 M(+8.4%)
Jun 2005
-
$1.97 M(+2.4%)
Mar 2005
-
$1.93 M(-23.8%)
Dec 2004
$2.53 M(+243.1%)
$2.53 M(+57.6%)
Sep 2004
-
$1.60 M(+16.7%)
Jun 2004
-
$1.37 M(+97.6%)
Mar 2004
-
$695.70 K(-5.6%)
Dec 2003
$737.00 K(+149.3%)
$737.00 K(-14.2%)
Sep 2003
-
$859.00 K(+6.8%)
Jun 2003
-
$804.10 K(+98.7%)
Mar 2003
-
$404.60 K(+36.9%)
Dec 2002
$295.60 K(+26.6%)
$295.60 K(-26.3%)
Sep 2002
-
$401.20 K(+1039.8%)
Jun 2002
-
$35.20 K(-90.9%)
Mar 2002
-
$387.80 K(+66.1%)
Dec 2001
$233.50 K(-65.8%)
$233.50 K(+36.6%)
Sep 2001
-
$170.90 K(+49.3%)
Jun 2001
-
$114.50 K(-56.3%)
Mar 2001
-
$262.20 K(-61.6%)
Dec 2000
$682.70 K(+183.5%)
$682.70 K(+142.3%)
Sep 2000
-
$281.80 K(+29.7%)
Jun 2000
-
$217.30 K(+3.3%)
Mar 2000
-
$210.30 K
Dec 1999
$240.80 K
-

FAQ

  • What is Marker Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Marker Therapeutics?
  • What is Marker Therapeutics annual current liabilities year-on-year change?
  • What is Marker Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Marker Therapeutics?
  • What is Marker Therapeutics quarterly current liabilities year-on-year change?

What is Marker Therapeutics annual total current liabilities?

The current annual current liabilities of MRKR is $3.07 M

What is the all time high annual current liabilities for Marker Therapeutics?

Marker Therapeutics all-time high annual total current liabilities is $28.01 M

What is Marker Therapeutics annual current liabilities year-on-year change?

Over the past year, MRKR annual total current liabilities has changed by -$4.71 M (-60.49%)

What is Marker Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of MRKR is $3.46 M

What is the all time high quarterly current liabilities for Marker Therapeutics?

Marker Therapeutics all-time high quarterly total current liabilities is $31.46 M

What is Marker Therapeutics quarterly current liabilities year-on-year change?

Over the past year, MRKR quarterly total current liabilities has changed by +$1.49 M (+75.48%)